C

Cormorant Asset Management, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Cormorant Asset Management, LLC with $1.3B in long positions as of Q3 2025, 67% allocated to Healthcare, and 67% concentrated in top 10 positions.

Portfolio Value
$1.3B
Top 10 Concentration
67%
Top Sector
Healthcare (67%)
US Exposure
83%
Market Cap Focus
Small Cap
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 67.10%Healthcare
Healthcare
67.10%

Industry Breakdown

1 industry across all sectors

Biotechnology: 67.10%Biotechnology
Biotechnology
Healthcare
67.10%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 4.82%Mid Cap ($2B - $10B): 25.31%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 61.43%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 4.79%N/A (ETF or Unknown): 3.64%
Large Cap ($10B - $200B)
4.82%
Mid Cap ($2B - $10B)
25.31%
Small Cap ($300M - $2B)
61.43%
Micro Cap ($50M - $300M)
4.79%
N/A (ETF or Unknown)
3.64%

Portfolio Concentration

Top 10 Holdings %
67.21%
Top 20 Holdings %
87.98%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
83.04%
International
16.96%
Countries
5
Largest Int'l Market
Netherlands - 7.47%
United States of America
83.04% ($1.1B)
29 holdings
Netherlands
7.47% ($95.9M)
2 holdings
Canada
6.24% ($80.1M)
2 holdings
Ireland
2.13% ($27.4M)
1 holdings
Switzerland
1.11% ($14.3M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
9.7 quarters
Avg. Top 20
9.6 quarters
Avg. All Positions
8.2 quarters
Median Holding Period
6 quarters
Persistence Rate
80.0%
Persistent Holdings Weight
74.68%
Persistent Positions
28
Longest Held
BridgeBio Pharma, Inc. Common Stock logo
BridgeBio Pharma, Inc. Common StockBBIO - 25 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
8.46%
Avg. Position Weight
2.86%
Largest Position
BBOT
BridgeBio Oncology Therapeutics, Inc. Common StockBBOT - 16.13%
Largest Ownership Stake
BBOT
BridgeBio Oncology Therapeutics, Inc. Common StockBBOT - 22.57%
Avg. Ownership Stake
7.66%
Ownership Stake >5%
8
Ownership Stake >1%
21

Historical (Since Q4 2013)

Avg. New Position
2.26%
Avg. Ownership Stake
4.56%
Largest Position
Aptose Biosciences, Inc. logo
Aptose Biosciences, Inc.APTO - 74.02% (Q2 2021)
Largest Ownership Stake
BBOT
BridgeBio Oncology Therapeutics, Inc. Common StockBBOT - 22.57% (Q3 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
20.5%
Value Traded
$263.23M
Positions Added
3
Positions Exited
9

Historical (Since Q4 2013)

Avg. Turnover Ratio
20.7%
Avg. Positions Added
8
Avg. Positions Exited
9
Highest Turnover
128.4%
Q4 2021
Lowest Turnover
6.5%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.